Merck v. USA, the best of ASCO, and Leqembi at the FDA

Put some mustard on your diction this Friday.

June 9, 2023 Check out STAT+

Sponsored By

Are drug prices protected by the Constitution? Will Medicare embrace Alzheimer's disease treatments? And should lawyers be allowed to use thesauruses? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. STAT Washington correspondent Rachel Cohrs joins us to explain Merck's lawsuit against the federal government and why the company believes drug pricing negotiation is "tantamount to extortion." We also discuss the health effects of Canadian wildfires, the highlights of the year's biggest cancer research conference, and what could be a watershed moment in the treatment of Alzheimer's.  Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser